Clinical Trials


Lymphoma Non-Transplant Trial Finder

Click on the headings below to view relevant trials for the condition listed.

Indolent Lymphoma: Newly Diagnosed/Untreated (1 trial)

  • Rituximab + Lenalidomide vs Chemotherapy (RELEVANCE-7636)
    A Phase 3 Open-Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma. The "RELEVANCE" Trial (Rituximab Lenalidomide Versus Any Chemotherapy)

Indolent Lymphoma: Relapsed/Refractory (6 trials, 2 pending)

Aggressive Lymphoma: Newly Diagnosed/Untreated (2 trials)

Aggressive Lymphoma: Relapsed/Refractory (5 trials, 2 pending)

Hodgkin Lymphoma: Newly Diagnosed/Untreated (0 trials)

  • Trials pending. None currently open.

Hodgkin Lymphoma: Newly Diagnosed/Advanced Stage (1 trial)

Hodgkin Lymphoma: Relapsed/Refractory (4 trials, 1 pending)

Mantle-Cell Lymphoma: Newly Diagnosed/Untreated (1 trial)

Mantle-Cell Lymphoma: Relapsed/Refractory (4 trials)

T-Cell Lymphoma (4 trials)

Chronic Lymphocytic Leukemia: Untreated or Consolidation (0 trials)

Trials pending. None currently open.

Chronic Lymphocytic Leukemia: Relapsed/Refractory (3 trials)

Clinical Trial Finder beta 2 updated 10/6/2014.